V03 Stock Analysis: VENTURE | SG
Electronic Components | SG, Singapore | Market Cap: 4.719m SGD | 12M Return: 20% | SG0531000230 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 13.7M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Venture Corporation Limited (SG: V03) is a Singapore-based provider of technology solutions, products, and services with operations spanning Asia Pacific and international markets. Incorporated in 1984 and headquartered in Singapore, the company operates as a diversified contract manufacturing and engineering services partner, offering capabilities that include product design and development, manufacturing, supply-chain management, customization, logistics, and aftermarket support. Its activities extend across the full electronics value chain, from printed circuit board assembly and plastic precision components to finished electronic, medical, and networking products.
The companys end-market exposure spans communications/networking equipment, medical and scientific instrumentation, consumer electronics, testing and measuring equipment, optical devices, and biotechnology/life sciences. Within the global Electronics Manufacturing Services (EMS) industry, contract manufacturers like Venture typically derive revenue from a mix of high-mix, low-volume industrial and medical customers alongside higher-volume consumer programs, often under multi-year supply agreements. This model is capital-light in design but requires significant working capital tied to components procurement and inventory management.
- Networking equipment revenue grows on AI data center demand
- Semiconductor capital equipment orders from key customers accelerate
- Medical device manufacturing margins expand on higher value-add services
| Net Income: 227.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -7.17 > 1.0 |
| NWC/Revenue: 72.24% < 20% (prev 65.96%; Δ 6.28% < -1%) |
| CFO/TA 0.07 > 3% & CFO 251.5m > Net Income 227.0m |
| Net Debt (-1.09b) to EBITDA (413.7m): -2.64 < 3 |
| Current Ratio: 2.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (287.4m) vs 12m ago -0.93% < -2% |
| Gross Margin: 27.62% > 18% (prev 25.95%; Δ 1.67% > 0.5%) |
| Asset Turnover: 69.84% > 50% (prev 77.38%; Δ -7.54% > 0%) |
| Interest Coverage Ratio: 386.4 > 6 (EBIT TTM 379.8m / Interest Expense TTM 983k) |
| A: 0.49 (Total Current Assets 2.76b - Total Current Liabilities 927.9m) / Total Assets 3.72b |
| B: 0.58 (Retained Earnings 2.15b / Total Assets 3.72b) |
| C: 0.10 (EBIT TTM 379.8m / Avg Total Assets 3.63b) |
| D: 2.95 (Book Value of Equity 2.77b / Total Liabilities 941.1m) |
| Altman-Z'' = 8.91 = AAA |
| DSRI: 1.14 (Receivables 651.6m/619.7m, Revenue 2.53b/2.73b) |
| GMI: 0.94 (GM 25.95% / 27.62%) |
| AQI: 0.96 (AQ_t 0.19 / AQ_t-1 0.20) |
| SGI: 0.93 (Revenue 2.53b / 2.73b) |
| TATA: -0.01 (NI 227.0m - CFO 251.5m) / TA 3.72b) |
| Beneish M = -3.05 (Cap -4..+1) = AA |
As of October 09, 2026, the stock is trading at SGD 16.30 with a total of 629,910 shares traded. Over the past week, the price has changed by -0.55%, over one month by -2.16%, over three months by -0.58% and over the past year by +20.04%.
Current recommended Stop Loss: 15.90 (which is 2.5% or 1.3 ATR below the current price).
VENTURE has no consensus analysts rating.
P/E Trailing = 20.2716
P/E Forward = 17.8571
P/S = 1.7961
P/B = 1.7264
P/EG = 2.0073
Revenue TTM = 2.53b SGD
EBIT TTM = 379.8m SGD
EBITDA TTM = 413.7m SGD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 16.2m SGD (Leases only: 16.2m)
Net Debt = -1.09b SGD (calculated: Debt 16.2m - CCE 1.11b)
Enterprise Value = 3.63b SGD (4.72b + Debt 16.2m - CCE 1.11b)
Interest Coverage Ratio = 386.4 (Ebit TTM 379.8m / Interest Expense TTM 983k)
EV/FCF = 16.23x (Enterprise Value 3.63b / FCF TTM 223.5m)
FCF Yield = 6.16% (FCF TTM 223.5m / Enterprise Value 3.63b)
FCF Margin = 8.83% (FCF TTM 223.5m / Revenue TTM 2.53b)
Net Margin = 8.96% (Net Income TTM 227.0m / Revenue TTM 2.53b)
Gross Margin = 27.62% ((Revenue TTM 2.53b - Cost of Revenue TTM 1.83b) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.98 (Enterprise Value 3.63b / Total Assets 3.72b)
Interest Expense / Debt = 6.05% (Interest Expense 983k / Debt 16.2m)
Taxrate = 19.96% (56.8m / 284.4m)
NOPAT = 304.0m (EBIT 379.8m * (1 - 19.96%))
Current Ratio = 2.97 (Total Current Assets 2.76b / Total Current Liabilities 927.9m)
Debt / Equity = 0.01 (Debt 16.2m / totalStockholderEquity, last quarter 2.77b)
Debt / EBITDA = -2.64 (Net Debt -1.09b / EBITDA 413.7m)
Debt / FCF = -4.89 (Net Debt -1.09b / FCF TTM 223.5m)
Total Stockholder Equity = 2.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.26% (Net Income 227.0m / Total Assets 3.72b)
RoE = 8.11% (Net Income TTM 227.0m / Total Stockholder Equity 2.80b)
RoCE = 13.61% (EBIT 379.8m / Capital Employed (Total Assets 3.72b - Current Liab 927.9m))
RoIC = 11.41% (NOPAT 304.0m / Invested Capital 2.66b)
WACC = 8.58% (E(4.72b)/V(4.74b) * Re(8.59%) + D(16.2m)/V(4.74b) * Rd(6.05%) * (1-Tc(0.20)))
Discount Rate = 8.59% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 45.88 | Cagr: 0.39%
[DCF] Terminal Value 72.25% ; FCFF base≈320.4m ; Y1≈281.0m ; Y5≈227.0m
[DCF] Fair Price = 16.02 (EV 3.51b - Net Debt -1.09b = Equity 4.60b / Shares 287.4m; r=8.58% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.97 | # QB: 1
Revenue Correlation: -99.69 | Revenue CAGR: -8.51% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=0.86 | Chg30d=+0.44% | Revisions=+17% | GrowthEPS=+9.6% | GrowthRev=+8.3%
EPS next Year (2027-12-31): EPS=0.93 | Chg30d=+0.99% | Revisions=+17% | GrowthEPS=+7.6% | GrowthRev=+6.6%
[Analyst] Revisions Ratio: +22% (up=4, down=2)